Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details

3 Resilient Blue-Chip Stocks To Buy Now

By MarketBeat.com (Sean Sechler )Stock MarketsNov 27, 2021 11:53PM ET
www.investing.com/analysis/3-resilient-bluechip-stocks-to-buy-now-200609712
3 Resilient Blue-Chip Stocks To Buy Now
By MarketBeat.com (Sean Sechler )   |  Nov 27, 2021 11:53PM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 

Resilient Blue-Chip Stocks Are Attractive In The Current Market Environment

What are some of the typical qualities that make a company resilient? It’s usually a business that can generate profits in almost any economic environment. With a strong brand name and products or services that always see steady demand, investors can count on these types of companies through thick and thin. Blue-chip stocks are a good example, as they are companies with strong balance sheets, stable cash flows, and business models that can stand the test of time.

Adding resilient blue-chip stocks to your portfolio makes a lot of sense at this time given the recent market volatility. With so many puzzling factors at play in the market and in the economy, targeting companies that offer reliability might be one of the smartest moves to make at the moment.

Let’s take a look at 3 resilient blue-chip stocks to buy now.

1. Microsoft

If you’re interested in a blue-chip tech company that has consistently proven it can adapt to new trends over the years, Microsoft (NASDAQ:MSFT) certainly fits the bill. The software company pivoted towards cloud computing at the perfect time, and now Microsoft Azure is providing entirely new growth prospects for long-term shareholders.

Products like Windows, Microsoft Office, Office 365, Sharepoint, and more are some of the most popular business software options in the world, which means the company consistently generates cash flows from them that it can reinvest in high-growth areas of the business like Azure.

Microsoft’s revenue grew by 22% year-over-year in Q2 to reach $45.3 billion, and the company continues to reward shareholders with consistent earnings growth. There’s also a lot to like about the company’s XBOX Series X gaming console, which could deliver a nice earnings boost for Microsoft as supply chain issues start to diminish.

The bottom line here is that Microsoft has a rock-solid net cash position, plenty of growth upside, and a history of creating innovative new products, making it one of the best blue-chip stocks on the market.

2. Pfizer

Even with Pfizer (NYSE:PFE) trading around its all-time highs, this blue-chip company could end up being a bargain at current levels. It’s a research-based global biopharmaceutical company that offers investors a nice balance of a strong existing drug portfolio and an intriguing pipeline of new drugs that could become future cash cows.

With best-selling drugs like Prevnar, Ibrance, and Eliquis, investors can count on stable earnings quarter after quarter here. Worldwide prescription drug sales are expected to grow at a compound annual growth rate of 7.4% from 2020 to 2026, which tells us that there is plenty of money to be made for a company like Pfizer.

Investors are probably already aware of the company’s COVID-19 vaccine, which helped Pfizer deliver a revenue jump of 134% year-over-year to $24.1 billion in Q3. The company’s antiviral COVID treatment pills could be another strong growth driver, and FDA approval of the treatment could send shares soaring in the coming weeks. Finally, the company’s 3.05% dividend yield is very attractive, and Pfizer also has a history of share buyback programs that make it a great choice for long-term investors.

3. McKesson Corp

Companies that are involved in the health care industry can certainly offer reliability, especially in the wake of the global pandemic. McKesson (NYSE:MCK) is a solid pick as its North America’s largest pharmaceutical distributor, which means the company plays a vital role in keeping our country healthy.

Along with pharmaceuticals, McKesson provides health information technology, medical supplies, and care management tools, which means it serves a broad range of health care customers. Perhaps what’s most attractive here is the fact that McKesson has a truly dominant market position, as it's one of three companies that operate as a pharmaceutical wholesale and distribution oligarchy.

The company reported total revenues of $66.6 billion in Q2, up 9% year-over-year, and increased its FY 22 outlook, which is another strong reason to consider adding shares. McKesson is also playing a big part in the fight against COVID-19 and has seen strong demand for products like COVID-19 tests, vaccines, and more in recent quarters.

Finally, the fact that McKesson is selling part of its European business is another plus to consider, as it will allow the company to focus on higher-growth areas of the business going forward.

Original Post

3 Resilient Blue-Chip Stocks To Buy Now
 

Related Articles

3 Resilient Blue-Chip Stocks To Buy Now

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email